Severe bacterial keratitis and activity of fluoroquinolones;Kératites bactériennes sévères et sensibilité des germes aux fluoroquinolones

Journal Francais d'Ophtalmologie

Volumn 32, Issue 4, 2009, Pages 273-276

  Mesplie N ^a   Kerautret J ^a   Leoni S ^a   Dubois, V ^a   Colin, J ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Fluoroquinolones; Resistance; Severe bacterial keratitis

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM; CHILD; DRUG EFFECT; HOSPITALIZATION; HUMAN; INFANT; KERATITIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; BACTERIA; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CHILD, PRESCHOOL; FLUOROQUINOLONES; HUMANS; INFANT; KERATITIS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 63749121989     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2008.12.002     Document Type: Article

References (13)

1. Kerautret J., Raboela L., and Colin J. Kératites bactériennes sévères : étude rétrospective clinique et microbiologique. J Fr Ophtalmol 29 (2006) 883-888
2. Bourcier T., and Chaumeil C. Kératites bactériennes. Infections cornéennes : diagnostic et traitement (2004), Elsevier SAS
3. Bourcier T., Thomas F., Borderie V., Chaumeil C., and Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87 (2003) 834-838
4. Alexandrakis G., Alfonso E.C., and Miller. Shifting trends in bacterial keratitis in south florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
5. Ly C.N., Pham J.N., Badenoch P.R., Bell S.M., Hawkins G., Rafferty D.L., and Mc Clellan K.A. Bacteria commonly isolated from keratitis specimen retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin. Clin Experiment Ophthalmol 34 (2006) 44-50
6. Oliveira A.D., D'Azevedo P.A., and Francisco W. In vitro activity of fluoroquinolones against ocular bacterial isolate in Sao Paulo, Brazil. Cornea 26 (2007) 194-198
7. Lin C.T., and Petersen-Jones. Antibiotic susceptibility of bacterial isolates from corneal ulcers of dogs in Taiwan. J Small Anim Pract 48 (2007) 271-274 Epub 2007
8. Blondeau J.M., Laskowski R., Bjarnason J., and Stewart C. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 gram-negative and gram-positive organisms. Int J Antimicrob Agents 14 (2000) 45-50
9. Pong A., Thomson K.S., Moland E.S., Chartrand S.A., and Sanders C.C. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. J Antimicrob Chemother 44 (1999) 621-627
10. Callegan M.C., Ramirez R., Kane S.T., Cochran D.C., and Jensen H. Antibacterial activity of 4-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 20 (2003) 246-252
11. Colin J., Simonpoli Sylvie, Geldsetzer K., and Ropo A. Corneal penetration of levofloxacin intrue the human aqueous humor: comparison with ciprofloxacin. Acta Ophthalmo Scand 81 (2003) 611-613
12. Raizman MB, Rubin JM, Graves AL, Rinehart M. Tear concentration of levofloxacin following topical administration of a single dose of 0,5 % levofloxacin ophthalmic solution in healthy volunteers. Clin Ther, 2002; 24: 1439-50. Erratum in: Clin Ther 2004; 26: 1700. Dosage error in text.
13. Healy D.P., Holland E.J., Nordlund M.L., Dunn S., Chow C., Lindstrom R.L., Hardten D., and Davis E. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea 23 (2004) 255